Search filters

List of works by Laurie H Sehn

A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma

scientific article

A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA

scientific article published on 06 June 2020

Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

scientific article

Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis

scientific article published on 08 April 2014

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

scientific article published on 21 November 2013

CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure

scientific article published on 11 February 2009

CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma

scientific article published on 01 June 2007

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

scientific article published on 5 July 2016

Cell of origin of transformed follicular lymphoma

scientific article

Clinical impact of pathology reviews of outside material: a patient-focused approach

scientific article published on 26 September 2011

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

scientific article published on 14 July 2016

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL

scientific article published on 11 December 2017

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

scientific article

Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP.

scientific article

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse ⬇️

scientific article published on April 12, 2011

Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.

scientific article

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival

scientific article

Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia

scientific article published on 06 June 2016

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.

scientific article published on 9 November 2017

Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes

scientific article published on 01 February 2003

Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma

scientific article published on 27 June 2016

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP.

scientific article published on 10 June 2008

Genetic polymorphism at BCL2 as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphoma

scientific article published on 2 February 2017

Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact.

scientific article published on 28 March 2017

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.

scientific article published on 4 June 2015

High-resolution architecture and partner genes of rearrangements in lymphoma with DLBCL morphology

article

Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas

scientific article published in March 2004

Impact of Concordant and Discordant Bone Marrow Involvement on Outcome in Diffuse Large B-Cell Lymphoma Treated With R-CHOP ⬇️

scientific article published on 07 March 2011

Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma

scientific article published on September 2015

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

scientific article

Interim PET-directed therapy in limited stage Hodgkin lymphoma initially treated with ABVD

scholarly article by Diego Villa et al published 12 July 2018 in Haematologica

International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era ⬇️

scientific article published on August 6, 2012

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

scientific article published on 13 June 2005

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab

scientific article

Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapy

scientific article published on 17 January 2012

MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab

scientific article published on 08 February 2014

Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas

scientific article published on 16 June 2016

Multicolour fluorescence in situ hybridization analysis of t(14;18)-positive follicular lymphoma and correlation with gene expression data and clinical outcome

scientific article

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

scientific article

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation

scientific article published on 03 January 2015

Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience

scientific article

Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia

scientific article published on 8 April 2015

Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study

scientific article published on 27 March 2018

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

scientific article published on 29 April 2008

Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases

scientific article published on 3 May 2017

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma

scientific article published on 6 October 2008

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies

scientific article

Prognostic factors in follicular lymphoma.

scientific article published on 12 April 2010

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

scientific article published on 01 September 2018

Site of central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) by the CNS-IPI risk model

scientific article published on 22 July 2016

Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors ⬇️

scientific article published on April 22, 2013

The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association.

scientific article

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

scientific article

The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency

scientific article published in March 2005

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome

scientific article published on 26 August 2011

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma.

scientific article

Paulina is supported by:

About Paulina

Help